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We report a facile and robust microfluidic method to fabricate polymeric core-shell
microspheres as delivery vehicles for biomedical applications. The characteristics of
core-shell microspheres can be precisely and easily tuned by manipulating the
microfluidic double emulsion templates. The addition of a shell can significantly
improve the versatility as well as functionality of these microspheres as delivery
vehicles. We demonstrate that the nature of the shell material plays an important role
in the properties of the core-shell delivery vehicles. The release kinetics is
significantly influenced by the material of the shell and other characteristics such as
the thickness. For example, by adding a poly(lactic-co-glycolic acid) (PLGA) shell to
an alginate core, the encapsulation efficiency is enhanced and undesired leakage of
hydrophilic actives is prevented. By contrast, adding an alginate shell to PLGA core
can lead to a reduction of the initial release rate, thus extending the release period of
hydrophobic actives. Microfluidic fabrication enables the generation of precisely
controlled core-shell microspheres with a narrow size distribution, which enables the
investigation of the relationship between the release kinetics of these microspheres
and their characteristics. The approach of using core-shell particles as delivery
vehicles creates new opportunities to customize the release kinetics of active
ingredients.VC 2013 AIP Publishing LLC. [http://dx.doi.org/10.1063/1.4819274]
INTRODUCTION
Polymer-based systems have been extensively studied as delivery vehicles of drugs, proteins,
peptides, and small interfering ribonucleic acid (siRNA).1–4 Polymer-based microspheres are con-
venient to fabricate, generally biocompatible, with tunable physical and chemical properties.
These attributes make them attractive for encapsulation and controlled release applications.3–6
Active ingredients can be trapped in the polymer matrices and released subsequently by diffusion
or degradation of polymer matrices. However, it remains a challenge to tailor the release profiles
from these polymeric microspheres to the need of applications. For instance, undesired initial
burst release of active ingredients from polymer microspheres remains difficult to avoid.7–9 This
challenges the ability to release ingredients in a sustained manner.7–10 Core-shell polymer-based
microspheres, with the additional shell whose properties can be tuned, offers more control over
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the release kinetics of the encapsulated active ingredients in the core. Active ingredients have to
diffuse through both the core and shell before they are released. By choosing proper shell materi-
als, the initial release rate can be reduced significantly and the overall release period can be pro-
longed. Release kinetics can be further adjusted by varying other characteristics of the shell, such
as its thickness. Besides, core-shell microspheres have several additional advantages. Fragile ther-
apeutic agents protected in the cores can be completely isolated by the shell from the surrounding
environment. Functional groups and reagents can be attached to the surface of the shell to achieve
targeted delivery. Active ingredients with different functions and properties can be encapsulated
separately in the core and the shell to realize co-delivery. Therefore, introduction of an additional
shell layer on polymeric microspheres can significantly improve their versatility as well as func-
tionality as delivery vehicles.
Although polymer-based core-shell microspheres show great promise in biomedical applica-
tions, the conventional fabrication method has limited their utilization. Conventional techniques
for generating double emulsion employs high shear, reducing the encapsulation efficiency.11,12
The resultant core-shell microspheres are polydisperse in size with little control over their char-
acteristics; moreover, the reproducibility is also poor. Therefore, a facile method for fabricating
monodisperse core-shell microspheres with precise control over the structure is desired.
Recent advances in microfluidics enable fabrication of monodisperse oil-in-water-in-oil
(O/W/O) or water-in-oil-in-water (W/O/W) double emulsion droplets in a highly controlled
fashion.13–17 These droplets are perfect templates for core-shell microspheres.16,17 Two different
polymers can be dissolved in two separate solvents, which will become the inner and middle
phases after microfluidic double emulsification. The resultant double emulsions can be solidified
to form core-shell microspheres. Active ingredients of different solubility can be encapsulated
separately in the core and the shell. One important advantage of microfluidics is the ability to
generate droplets one-by-one;18 this offers intricate control over the structure of the final micro-
spheres. The characteristics, such as core size and shell thickness, can be easily and precisely
manipulated. This allows the investigation of the relationship between the structure and the
release kinetics of the delivery vehicles. Another important advantage of microfluidics is the
narrow size distribution; this enables investigation of the relationship between size and release
kinetics.
In this paper, we choose two common biocompatible polymers, alginate extracted from
algae and poly(lactic-co-glycolic acid) (PLGA), a Food and Drug Administration (FDA)-
approved material with tunable degradation rate, as model materials to form core-shell spheres.
Alginate microgel spheres have been extensively employed to encapsulate cells, biomolecules
and hydrophilic drugs.19–22 PLGA is well-developed for controlled release of hydrophobic
drugs.6,7,11 Despite the pervasiveness of these two polymers, studies using alginate/PLGA or
PLGA/alginate core-shell microspheres as delivery vehicles for controlled release applications
remain limited. We fabricate alginate/PLGA and PLGA/alginate core-shell microspheres from
W/O/W and O/W/O double emulsion droplets, respectively. We show that the structure of our
microspheres can be tuned easily either by changing the flow rates, device geometry, or osmotic
pressure. We show that hydrophilic and hydrophobic active ingredients can be encapsulated in
the cores and shells, respectively. We further demonstrate that the initial burst release is
reduced and the overall release period from our core-shell microspheres is prolonged.
Therefore, these core-shell microspheres are suitable for applications where sustained release
profiles are required. Our core-shell microspheres provide a microscale platform for co-delivery
and controlled release of therapeutic agents of different solubility.
EXPERIMENTS
Materials
Poly(vinyl alcohol) (PVA, 87%–89%, hydrolyzed, average Mw¼ 13 000–23 000),
poly(D,L-lactide-co-glycolide) (PLGA, ester terminated, L/G¼ 50:50, Mw 7000–17 000), rifam-
picin (97%, powder), anhydrous calcium chloride, nonionic surfactant sorbitane monooleate
(Span 80) and Oil Red O are purchased from Sigma-Aldrich. Alginate in the form of alginic
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acid sodium salt was purchased from Fluka. Surfactant Dow Corning 749 fluid is purchased
from Dow Corning Corporation. Dichloromethane (DCM) is purchased from Lab-scan
Analytical Science. Toluene is purchased from BDH Prolabo Chemicals.
Generation of double emulsions
We use a capillary microfluidic device to generate monodisperse W/O/W and O/W/O dou-
ble emulsions, respectively.13–18 In a typical capillary microfluidic double-emulsion device, two
cylindrical capillaries (World Precision Instrument, Inc.), which have an inner diameter and an
outer diameter of 0.58mm and 1mm, respectively, are tapered using a micropipette puller
(P-97, Sutter Instrument, Inc.). The tips of the capillaries are polished to desired diameters
using a sand paper. Typical tip diameters of the injection and collection capillaries are 25 lm
and 100 lm, respectively. Then the polished round capillaries are coaxially aligned inside a
square capillary (AIT glass). By combining the co-flow and flow-focusing geometries, the de-
vice can be used for generating monodisperse double emulsions, as shown by the schematic in
Figure 1(A). By hydrophobizing different parts of the capillaries using n-octadecyltrimethoxy
silane (Aldrich), the resultant device was used to generate oil-in-water-in-oil (O/W/O) or water-
in-oil-in-water (W/O/W) double emulsions, respectively.
This device geometry works well when the viscosities of the fluid phases are of similar val-
ues. Typically, the inner phase is pumped through one tapered round capillary, often known as
the injection capillary; the middle phase flows through the region between the injection capil-
lary and the square capillary in the same direction. The inner aqueous droplets form by dripping
from the tip of the inner round injection capillary in the co-flow geometry. The outer aqueous
phase flows through the region between the other round capillary, often known as the collection
capillary, and the square capillary, in the opposite direction. The outer phase hydrodynamically
focuses the middle phase containing the innermost droplets; the resultant jet breaks up into
monodisperse double-emulsion drops at the orifice of the collection capillary, as shown by the
schematic in Figure 1(A).
We use this device geometry to generate W/O/W double emulsion templates to fabricate
alginate-PLGA core-shell microspheres. The inner phase of the double emulsion templates con-
sists of deionized (DI) water with 0.5% sodium alginate and 10% (w/v) PVA; DCM with 20%
(w/v) PLGA (50:50) is used as the middle oil phase. DCM is a frequently used organic solvent
for PLGA and evaporates quickly at room temperature. The outermost aqueous phase consists
of DI water with 10% (w/v) PVA and 4% calcium chloride (CaCl2). The viscosities of the
inner, middle, and outer phases in our experiments are 1.44mm2/s, 1.8mm2/s, 3.36mm2/s,
respectively. Typical flow rates of the three phases we use to generate the W/O/W double emul-
sions are 200, 800, and 2000ll/h, respectively.
However, when the viscosity of the middle phase exceeds the viscosity of the outer phase
significantly, fluid flow in devices with this geometry becomes ill-controlled. To generate O/W/O
double emulsions templates for fabrication of PLGA-alginate core-shell microspheres. We use
dichloromethane with 8% (w/v) PLGA as inner phase, 0.5% (w/v) sodium alginate, and 1% (w/v)
PVA as middle phase and the outer phase is made up of toluene with 10% (w/v) span 80. The
FIG. 1. (A) Schematic of a typical capillary microfluidic device geometry and generation of double emulsion droplets; (B)
schematic of ill-controlled fluid flow with increasing difference in the flow rates of the outer and middle phases when the
viscosity of middle phase is 27.5 times higher than that of the outer phase; (C) schematic of the modified capillary micro-
fluidic device geometry; and (D) comparison of the typical and modified device geometries.
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viscosities of inner, middle, and outer phases are 1.8mm2/s, 27.5mm2/s, and 1mm2/s, respec-
tively. In this case, the middle phase is highly viscous; to break up the middle phase jet, the flow
rate difference between the middle and outer phases (QouterQmiddle) must be significantly
increased. However, when the difference in flow rates is too large, the middle phase ceases to
form a stable jet, as shown in Figure 1(B). A common method to address this problem is to mini-
mize the difference in viscosities by choosing the appropriate compositions in the different
phases. However, this significantly limits the choice of the materials.
To solve this problem, we modify the geometry of the device slightly and insert the injec-
tion capillary into the collection capillary, as shown in Figure 1(C). With this new geometry,
the velocity of the middle phase v increases significantly due to the decrease in the jet radius r,
under the same flow rate Q, v¼ 4Q/pr2, as shown by the resultant jets in Figure 1(D). The
decrease in the middle jet diameter is due to the insertion of injection capillary. The flow rates
of the three phases we use in generating O/W/O double emulsions are 400, 500, and 500ll/h,
respectively.
Characterization of core-shell microspheres
The morphology of the resultant core-shell microspheres is characterized using an optical
microscope (Nikon Eclipse 80i) and a scanning electron microscope (Hitachi S3400N VP
SEM). To obtain the size distribution of the microspheres, we measure at least 100 micro-
spheres for each diameter by analyzing microscope images using the open-source image analy-
sis software, Image J.
RESULTS AND DISCUSSION
To encapsulate, deliver and release active ingredients in a sustained manner, one of the
most frequently employed methods is to trap active ingredients in polymer matrices with tuna-
ble degradation rate in the form of microspheres.1–10 PLGA is a well-developed biocompatible
polymer with a tunable degradation rate, and is extensively employed in the controlled release
of drugs.6,7,11
However, single PLGA microspheres are typically limited by a low loading efficiency for
hydrophilic actives due to the hydrophobic nature of PLGA, and it remains difficult to tailor
their release kinetics and avoid undesired release patterns.7–10 These difficulties can be over-
come by using composite microspheres with complex structures, such as core-shell composite
microspheres. To enhance the encapsulation efficiency for hydrophilic actives, a core of hydro-
philic nature can be incorporated inside the PLGA microspheres. To avoid undesired release
patterns from PLGA microspheres, a shell made from materials enabling different release mech-
anisms can be added to modulate release kinetics.
Double emulsion droplets are excellent templates for fabricating core-shell microspheres.
W/O/W or O/W/O double emulsion templates can be employed, depending on the solubility of
active ingredients to be encapsulated. Monodisperse, size-controlled W/O/W and O/W/O double
emulsions are routinely generated using capillary microfluidic techniques. The exquisite control
of droplet generation allows manipulation over the characteristics of the final microspheres,
such as their size and core-to-shell ratio. To tailor these characteristics, we use a simple theoret-
ical model to predict the size of emulsion droplets under flow-induced dripping regime.18,23 In
the dripping regime, when the capillary number, Ca, which is the ratio of shear Fshear and inter-
facial forces Fr, reaches a critical value, typically on the order of 1, droplets detach from the
nozzle and flow downstream. The size of the generated emulsion droplet can be predicted by
solving Eq. (1),18,23
Fshear ¼ CacriticalFr: (1)
For double emulsions, when the breakup of the middle phase forces the inner phase to
break up, we can treat the middle phase containing the innermost phase as a single dispersed
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phase detaching from the nozzle. In this case, the shear force and interfacial tension on middle
phase fluid, F2,shear and F2,r, are represented by Eqs. (2) and (3), respectively,
F2;shear ¼ 3pl3ðd2  d2threadÞðv3  v2Þ; (2)
F2;c ¼ pd2threadc2;3; (3)
where l3 is the viscosity of the outer phase fluid, dcap is the diameter of the injection capillary,
and d2thread is the diameter of the fluid thread formed in the co-flowing middle fluids. The value
of d2thread can be approximated by mass balance: d2thread ¼ Dc
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiðQ1 þ Q2Þ=ðQ1 þ Q2 þ Q3Þ
p
,
where Dc is the diameter of the collection capillary. Q1, Q2, Q3 are the volumetric flow rates of
the inner, middle, outer phase fluids, respectively. !2,3 define the surface tension between mid-
dle and outer fluids. v2, v3 represent the average velocities of the middle and the outer phases,
respectively, where v2 ¼ 4Q2=pðd22  d21Þ, v3 ¼ 4Q3=pðD2c  d22Þ.
By solving Eqs. (1)–(3), the size of the whole droplet size d2 can be predicted (Eq. (4)),
while the size of inner droplet size, d1, can be predicted using mass balance, as shown by
Eq. (5).23,24
d42 þ C2;3ðQ3 þ QÞd32  ðC2;3d2threadðQ3 þ QÞ þ D2cÞd22  C2;3QD2cd2 þ C2;3QD2cd2thread ¼ 0;
(4)
Q ¼ Q2=½1 ðQ1=ðQ2 þ Q1ÞÞ2=3; C2;3 ¼ 12l3=pCa2;3ðd2threadc2;3 þ dcapc1;2Þ
d1 ¼ ½Q1=ðQ1 þ Q2Þ
1
3d2: (5)
However, if the inner phase breaks up first and triggers the middle phase to pinch off, the
prediction by Eqs. (4) and (5) is not accurate. This case is common in the modified geometry
as shown in Figure 1(C). The velocity of middle phase jet is accelerated under the same flow
rate, implying that middle phase exerts a higher shear force on the inner phase. Thus, the inner
phase fluid is more likely to pinch off in the modified geometry. Moreover, when the viscosity
of middle fluid is high, the middle phase jet will break up considerably more slowly even under
a large shear force. This also causes the inner fluid to break up before the middle fluid does.
Therefore, for the cases where the break-up of inner phase triggers the formation of double
emulsion droplets, we predict the inner droplet size d1 and the overall droplet size d2 based on
the critical capillary number and mass balance, respectively,
F1;shear ¼ 3pl2ðd1  dcapÞðv2  v1Þ; (6)
F1;c ¼ pdcapc1;2; (7)
where F1,shear and F1,! are the shear force exerted by middle phase and pinning force caused by
surface tension, respectively.
d1 can be predicted by solving Eqs. (1), (6), and (7)
26 and d2 can be predicted by mass bal-




In our W/O/W double emulsion system, the middle jet breaks up first at the orifice of the
collection capillary to form monodisperse droplets, as shown in Figure 2(A). We test the va-
lidity of Eqs. (4) and (5) by comparing the droplet sizes observed experimentally. The surface
tension value for the bare interfaces between the middle-outer phases is c2,3¼ 25.2mN/m.
The tip diameters of our injection and collection capillary are 18 lm and 88 lm, respectively.
An increase in Q1 leads to increases of d1 and d2 while keeping other flow rates constant;
whereas an increase in Q2 results in a decrease in d1 and an increase in d2. The predicted val-
ues are in agreement with the experimental values acquired by image analysis, as shown in
Figures 2(B) and 2(C). However, in our O/W/O emulsion systems, where the viscosity of
middle phase is 27.5 times higher than that of the outer phase, the inner phase breaks up first
and triggers the middle phase to pinch off, as shown in Figure 2(D). In this case, Eqs. (4) and
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(5) fail to predict the size of the generated double emulsion droplets. Increase in Q1 will
speed up the growth of the inner droplet in size and expedite its detachment from the capil-
lary tip. As the inner fluid quickly moves into the collection capillary, this causes the middle
fluid to break up before its critical capillary number is reached, leading to a decrease in d2
and thinner shells. However, Eq. (5) suggests that d2 increases with increasing Q1 and clearly
contradicts the experimental observation. To address this, we predict d1 and d2 by solving
Eqs. (6) and (7). The surface tension for the interface between inner and middle phase is
14mN/m. The diameters of injection capillary and collection capillary are 25 lm and 80 lm,
respectively. The derivation of Eqs. (6) and (7) indicates that d1 increases with an increasing
Q1 and a decreasing Q2 while d2 increases with a decreasing Q1 and an increasing of Q2. The
experimental data by image analysis agrees reasonably well with the prediction by Eqs. (6)
and (7), as shown in Figures 2(E) and 2(F).
Due to the high degree of control offered by microfluidics, the size of emulsion droplets
can also be tuned by varying the osmotic pressure difference between the inner and outer aque-
ous phases.25 Due to the presence of a concentration gradient, when the osmolality of the inner
phase is lower than that of outer phase, the solvent in the inner droplets start to diffuse out and
causes the inner droplets to shrink, as shown in Figure 3(A). Before droplets are solidified, a
large osmolality difference leads to a significant reduction in the inner and whole droplet size,
as shown in Figure 3(B).
After the formation of W/O/W and O/W/O emulsion droplets, the droplets are solidified
into monodisperse core-shell alginate-PLGA and PLGA-alginate microspheres, respectively. For
W/O/W emulsion droplets, calcium ions in the outer phase diffuse through the oil layer and
crosslink the alginate in the inner droplets to form calcium alginate microspheres, as shown in
Figures 4(A) and 4(B). PLGA in the oil layer solidifies to form a shell that surrounds alginate
microspheres after the complete evaporation of DCM. The resultant core-shell particles are
shown in Figure 4(C). Silver nanoparticles and a hydrophobic dye, Oil Red O, are added to the
inner and middle phases, respectively, as model hydrophilic and hydrophobic active ingredients.
They are encapsulated in the cores and the shells of the resultant microspheres as shown in
Figure 4(D). The O/W/O emulsion droplets are collected in a mixture of ethanol and calcium
chloride with a volume ratio of 1:3. The calcium ions in the collection mixture diffuses into the
droplet shells and crosslink the sodium alginate, resulting in solidified PLGA microspheres sur-
rounded by calcium alginate shells, as illustrated in Figure 4(E). Due to its miscibility with
both water and toluene, ethanol is added to speed up the diffusion of calcium ions. The result-
ant core-shell microspheres are shown in Figures 4(F) and 4(G); the alginate shell is stained
FIG. 2. Optical microscopic images of (A) microfluidic generation of W/O/W double emulsions; inner droplet size d1 and
the whole droplet size d2 are predicted using Eqs. (4) and (5) (blue symbols) and compared with size measured through
image analysis (red symbols) for changing Q1 (B) and Q2 (C) while keeping other flow rates constant. Optical microscopic
images of (D) microfluidic generation of monodisperse O/W/O double emulsion droplets in a modified geometry; inner
droplet size d1 and the whole droplet size d2 are predicted using Eqs. (6) and (7) (blue symbols) and compared with sizes
measured by image analysis (red symbols) for changing Q1 (E) and Q2 (F) while keeping other flow rates as constant.
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with alcian blue for visualization, as shown in Figure 4(G). The core-shell structure is con-
firmed by variable-pressure SEM with core size and overall particle size are 53.2lm and
68.5 lm, respectively, as shown in Figure 4(H).
With alginate-PLGA and PLGA-alginate core-shell microspheres, the functionality as well
as versatility as a potential drug carrier is improved, when compared to single microspheres.
For alginate-PLGA microspheres, the alginate cores have a high loading efficiency for hydro-
philic actives, while PLGA shells can prevent undesired leakage and release these encapsulated
actives in a sustained manner. For PLGA-alginate microspheres, the alginate shells can modu-
late release kinetics of hydrophobic actives from PLGA cores. Typical high initial drug release
FIG. 3. (A) Optical microscopic image demonstrating droplet size change over time due to a difference in osmolality
between the inner and the continuous phases; (B) A plot of the droplet size reduction as a function of differences in osmo-
lality before solidification.
FIG. 4. Optical microscopic image of (A) collection of W/O/W double emulsion droplets, (B) schematic illustrating the sol-
idification of an emulsion droplet into alginate-PLGA core-shell microspheres, (C) and (D) optical microscope images of
alginate-PLGA core-shell microspheres with silver nanoparticles and dye Oil Red O encapsulated in the core and shell,
respectively, (E) schematic illustration of the collection of emulsion droplets that subsequently solidifies due to crosslinking
by the calcium ions, (F) and (G) optical microscopic image, and (H) variable-pressure SEM image of PLGA-alginate core-
shell microspheres. The alginate shells are stained for visualization in (G).
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rate from PLGA microspheres is largely due to rapid release of drugs from the surface. With al-
ginate shells, drugs on the surface of PLGA cores must first diffuse through the alginate matri-
ces before release; as a result, the initial release rate is reduced and the release period is pro-
longed.26 This is favorable in most sustained release applications since a high initial release
rate usually leads to a loss of active ingredients and thus a shortened release period.
Release profile from core-shell microspheres can be designed by tailoring shell properties
such as the mesh size of matrices and shell thickness to achieve profiles difficult to achieve
with single microspheres. The monodispersity of core-shell microspheres enables the investiga-
tion of the relationship between the release kinetics and microstructures. This potentially ena-
bles pre-determined release profile of actives.
Our core-shell microspheres can encapsulate and release active ingredients of different
properties in a sustained manner. By choosing a combination of materials with different release
mechanisms, a diverse range of release profile can be tailor-designed based on the needs of
applications. This makes them suitable for delivery of drugs, proteins and genes for biomedical
research and applications.
CONCLUSIONS
Polymer-based systems are promising delivery vehicles for biomedical applications. Core-
shell structured polymeric microspheres demonstrate multiple functionalities, when comparing
with conventional single microspheres. Core-shell polymer microspheres fabricated by micro-
fluidics are monodisperse, with precisely and easily tuned core size and shell thickness. Release
kinetics is significantly influenced by incorporating a shell layer. By inserting an alginate core
to PLGA microspheres, the encapsulation efficiency is enhanced and delicate hydrophilic active
ingredients such as DNA and siRNA are protected from organic solvent by the hydrogel core.
Similarly, an alginate shell can also be added to PLGA cores; this reduces the initial release of
the active ingredient, thus extending the overall release period. The effect of shell properties,
such as shell thickness and porosity, can be manipulated to modulate the release profile from
core-shell particles. The approach of using core-shell particles as delivery vehicles also enables
co-delivery of active ingredients with different solubility by encapsulating them separately in
the core and the shell. Monodisperse polymer-based core-shell microspheres provide a platform
for systematic studies of controlled release. Furthermore, the monodispersity and reproducibility
of these microspheres suggest new opportunities to investigate the relationship between charac-
teristics of microspheres and their release kinetics. This will provide the information needed for
tailoring the release profile to the need of the application. Moreover, additional functional
groups and reagents can be incorporated into the shell to realize targeted delivery and on-
demand release. Therefore, core-shell particles represent a first step towards delivery vehicle
that can deliver and release the needed amount of active ingredients to the target location with
high efficiency upon specific triggers.
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